A 56-year-old man comes to the physician for evaluation of gradually worsening fatigue, increased urinary frequency, and blurry vision for 5 months. He has not seen a doctor in several years. Physical examination shows decreased vibratory sense and proprioception in the lower extremities. His hemoglobin A1c is 10.4%. Treatment for his condition with an appropriate medication is begun. In response to this drug, pancreatic islet cells begin producing increasing amounts of secretory granules. The patient was most likely treated with which of the following drugs?
Q62
An investigator is studying the principles of cell-to-cell signaling of the autonomic nervous system. It is found that the adrenal medulla has receptors that, when activated, result in the immediate opening of Na+, Ca2+, and K+ channels, which subsequently leads to the secretion of epinephrine and norepinephrine. These receptors are structurally most similar to which of the following receptors?
Q63
A 36-year-old woman is brought to the emergency department after a high-speed motor vehicle collision. Her temperature is 36.5°C (97.7°F), pulse is 120/min, respirations are 24/min, and blood pressure is 100/65 mm Hg. Examination shows second and third-degree burns covering 30% of the surface area of her body. Intravenous fluids are administered. 30 minutes later, the patient develops respiratory distress and requires intubation. Administration of succinylcholine during the procedure is most likely to increase this patient's risk of developing which of the following laboratory abnormalities?
Q64
A 36-year-old man comes to the physician for a routine health maintenance examination. He has a 20-year history of seizure disorder characterized by sudden-onset, periodic, jerking movements of both arms and lip smacking. He has a history of intravenous cocaine use. His temperature is 37.1°C (98.8°F), pulse is 80/min, respirations are 13/min, and blood pressure is 130/75 mm Hg. Examination shows gingival tissue covering the upper third of the teeth. There is bleeding of the gums when touched with a fine instrument. The remainder of the examination shows no abnormalities. Which of the following is the most likely cause of this patient's symptoms?
Q65
A 39-year-old man presents to the primary care physician complaining of 6 months of increasing dyspnea and non-productive cough. He has a past medical history of asthma, hypertension, obesity, and hypercholesterolemia. On examination, you notice that he takes shallow breaths and the respiratory rate is 22/min. On auscultation, you notice bibasilar rales, wheezes, and a grade 2/6 holosystolic murmur. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, and heart rate 74/min. He then undergoes an outpatient high-resolution chest computed tomography (CT) scan which reveals bibasilar honeycombing, a calcified granuloma, and a mildly enlarged mediastinal lymph node. Which of the following medications can cause or contribute to this man’s lung disease?
Q66
A 50-year-old man presents to an ophthalmologist with progressive decrease in his visual acuity over the last 6 months. He also mentions that he has become excessively sensitive to light over the same duration. Past medical history is significant for schizophrenia diagnosed in early adulthood which has been managed with an antipsychotic medication for the past 20 years. The ophthalmologist performs a slit lamp examination and notes discrete brown deposits on the corneal epithelium in both eyes. Which of the following antipsychotic drugs has this patient most likely been taking?
Q67
A 68-year-old male with congestive heart failure recently had his medication regimen adjusted to better control his hypertension. Three weeks later, laboratory analysis shows his serum calcium and magnesium levels have both decreased. The diuretic used in this patient acts predominantly on which nephron segment:
Q68
A 47-year-old man with alcoholic cirrhosis is brought to the emergency department by ambulance 20 minutes after being involved in a high-speed motor vehicle collision. His pulse is 120/min, respirations are 28/min and labored, and blood pressure is 70/40 mm Hg. Physical examination shows ecchymoses over the trunk and abdomen. In preparation for an exploratory laparotomy, atracurium is administered as an anesthetic. Which of the following characteristics is the most likely reason that this drug was chosen over other drugs in the same class?
Q69
A 52-year-old woman with hypertension and type 2 diabetes mellitus comes to the physician because of a 1-day history of severe pain and swelling of her left great toe. She has had similar episodes sporadically over the past 3 years. She drinks 6 beers daily. She does not smoke or use illicit drugs. She is allergic to hydrochlorothiazide and glipizide. Her current medications are amlodipine and metformin. Examination shows erythema, warmth, and tenderness of the left first metatarsophalangeal joint and a nodule over the right elbow. The most appropriate next step in treatment is the administration of a drug that has which of the following mechanisms of action?
Q70
A 20-year-old premedical student travels abroad for a global health service semester and presents to the local clinic with palpitations. She initially dismissed these symptoms as a side effect of working too hard; however, she has been noticing that these episodes have increased in frequency. Otherwise, she has had headaches and episodes of sweating, but she says that many members of her family have migraines. In the clinic, her temperature is 99°F (37°C), blood pressure is 170/120 mmHg, pulse is 105/min, respirations are 20/min. Other laboratory testing is not available. The doctor provides an older medication that he says does not bind to the relevant receptor but instead blocks an upstream process. The drug provided most likely has which of the following mechanisms of action?
Autonomic/CV Drugs US Medical PG Practice Questions and MCQs
Question 61: A 56-year-old man comes to the physician for evaluation of gradually worsening fatigue, increased urinary frequency, and blurry vision for 5 months. He has not seen a doctor in several years. Physical examination shows decreased vibratory sense and proprioception in the lower extremities. His hemoglobin A1c is 10.4%. Treatment for his condition with an appropriate medication is begun. In response to this drug, pancreatic islet cells begin producing increasing amounts of secretory granules. The patient was most likely treated with which of the following drugs?
A. Glimepiride (Correct Answer)
B. Metformin
C. Insulin
D. Pioglitazone
E. Acarbose
Explanation: ***Glimepiride***
- **Glimepiride** is a sulfonylurea that stimulates pancreatic beta cells to increase **insulin secretion**, leading to an increase in secretory granules.
- The patient's symptoms (fatigue, polyuria, blurry vision, neurological deficits) and **high HbA1c (10.4%)** are consistent with poorly controlled **Type 2 Diabetes Mellitus**, for which sulfonylureas are an appropriate treatment.
*Metformin*
- **Metformin** primarily reduces **hepatic glucose production** and improves insulin sensitivity in peripheral tissues, rather than directly increasing insulin secretion or secretory granules from beta cells.
- While it is a common first-line treatment for Type 2 Diabetes, its mechanism of action does not involve increasing pancreatic islet cell secretory granules.
*Insulin*
- While insulin would effectively lower blood glucose, it is an **exogenous hormone** and does not stimulate the patient's own pancreatic beta cells to produce more secretory granules.
- Insulin therapy is often used in cases of beta-cell exhaustion or severe hyperglycemia, but the question specifies a drug that increases **pancreatic islet cell production** of granules.
*Pioglitazone*
- **Pioglitazone** is a thiazolidinedione that improves **insulin sensitivity** in peripheral tissues by activating PPAR-gamma receptors.
- It does not directly stimulate the pancreas to increase insulin secretion or the number of secretory granules.
*Acarbose*
- **Acarbose** is an alpha-glucosidase inhibitor that works by delaying **carbohydrate absorption** in the gut, thereby reducing postprandial glucose spikes.
- Its mechanism does not involve any direct effect on pancreatic islet cell insulin production or secretory granules.
Question 62: An investigator is studying the principles of cell-to-cell signaling of the autonomic nervous system. It is found that the adrenal medulla has receptors that, when activated, result in the immediate opening of Na+, Ca2+, and K+ channels, which subsequently leads to the secretion of epinephrine and norepinephrine. These receptors are structurally most similar to which of the following receptors?
A. Alpha 1 receptors of the bladder neck
B. D2 receptors of the basal ganglia
C. M2 receptors of heart
D. NM receptors of the quadriceps femoris muscle (Correct Answer)
E. H2 receptors of the stomach
Explanation: ***NM receptors of the quadriceps femoris muscle***
- The adrenal medulla's chromaffin cells are modified **postganglionic sympathetic neurons** that release catecholamines upon stimulation by preganglionic neurons.
- The activation of **Na+, Ca2+, and K+ channels** leading to rapid depolarization and neurotransmitter release is characteristic of **nicotinic acetylcholine receptors (NM type)**, which are ligand-gated ion channels.
*Alpha 1 receptors of the bladder neck*
- **Alpha-1 receptors** are **G-protein coupled receptors** that primarily activate phospholipase C, leading to increased intracellular calcium and smooth muscle contraction.
- Their activation does not directly result in the immediate opening of Na+, Ca2+, and K+ channels.
*D2 receptors of the basal ganglia*
- **D2 receptors** are **G-protein coupled receptors**, specifically inhibitory (Gi-coupled), that decrease adenylyl cyclase activity and reduce intracellular cAMP.
- They do not function as direct ligand-gated ion channels.
*M2 receptors of heart*
- **M2 receptors** are **G-protein coupled receptors** (Gi-coupled) that decrease heart rate by inhibiting adenylyl cyclase and opening potassium channels indirectly via G-protein subunits.
- While they affect ion channels, this is an indirect G-protein mediated process, not a direct ligand-gated ion channel mechanism.
*H2 receptors of the stomach*
- **H2 receptors** are **G-protein coupled receptors** (Gs-coupled) that increase adenylyl cyclase activity, leading to increased cAMP and stimulation of gastric acid secretion.
- They are not ligand-gated ion channels and do not directly open Na+, K+, and Ca2+ channels.
Question 63: A 36-year-old woman is brought to the emergency department after a high-speed motor vehicle collision. Her temperature is 36.5°C (97.7°F), pulse is 120/min, respirations are 24/min, and blood pressure is 100/65 mm Hg. Examination shows second and third-degree burns covering 30% of the surface area of her body. Intravenous fluids are administered. 30 minutes later, the patient develops respiratory distress and requires intubation. Administration of succinylcholine during the procedure is most likely to increase this patient's risk of developing which of the following laboratory abnormalities?
A. Hyperkalemia (Correct Answer)
B. Hypermagnesemia
C. Hypernatremia
D. Hyperglycemia
E. Hyperphosphatemia
Explanation: ***Hyperkalemia***
- Succinylcholine, a **depolarizing neuromuscular blocker**, can cause an acute, life-threatening release of potassium from muscle cells, especially in patients with burns, trauma, denervation, or prolonged immobilization.
- This is due to an upregulation of **extrajunctional nicotinic acetylcholine receptors** on the muscle surface following burn injury or muscle damage, leading to an exaggerated potassium efflux when activated by succinylcholine.
- **Clinical timing**: The risk of hyperkalemia is greatest from **24-48 hours post-burn through several months**, though succinylcholine should generally be avoided in burn patients due to this potentially fatal complication.
- The serum potassium can rise acutely by 5-10 mEq/L, causing **cardiac arrhythmias and cardiac arrest**.
*Hypermagnesemia*
- **Hypermagnesemia** is typically seen in patients with renal failure or those receiving excessive magnesium administration (e.g., in preeclampsia treatment).
- It does not directly result from succinylcholine administration, nor is it a common complication of burns unless exogenous magnesium is given.
*Hypernatremia*
- **Hypernatremia** is usually caused by conditions like dehydration, diabetes insipidus, or excessive intake of sodium.
- Succinylcholine does not directly affect serum sodium levels to cause hypernatremia.
*Hyperglycemia*
- **Hyperglycemia** can occur in trauma and burn patients due to increased stress hormones (e.g., cortisol, catecholamines) and insulin resistance.
- While stress-induced hyperglycemia is a possibility in this patient, succinylcholine itself does not directly cause hyperglycemia.
*Hyperphosphatemia*
- **Hyperphosphatemia** is usually associated with **renal failure**, rhabdomyolysis, or tumor lysis syndrome.
- Succinylcholine is not known to cause a significant increase in serum phosphate levels.
Question 64: A 36-year-old man comes to the physician for a routine health maintenance examination. He has a 20-year history of seizure disorder characterized by sudden-onset, periodic, jerking movements of both arms and lip smacking. He has a history of intravenous cocaine use. His temperature is 37.1°C (98.8°F), pulse is 80/min, respirations are 13/min, and blood pressure is 130/75 mm Hg. Examination shows gingival tissue covering the upper third of the teeth. There is bleeding of the gums when touched with a fine instrument. The remainder of the examination shows no abnormalities. Which of the following is the most likely cause of this patient's symptoms?
A. Nifedipine
B. Phenytoin (Correct Answer)
C. Phenobarbital
D. Carbamazepine
E. Topiramate
Explanation: ***Phenytoin***
- The patient's history of a **seizure disorder** treated with medication, combined with **gingival hyperplasia** and bleeding gums, strongly suggests chronic **phenytoin use**.
- Phenytoin is a well-known cause of **gingival overgrowth** (occurs in ~50% of patients), which is a **dose-independent side effect** related to altered collagen metabolism.
- The overgrowth is exacerbated by poor oral hygiene and commonly presents with bleeding on probing.
*Nifedipine*
- While nifedipine, a **calcium channel blocker**, can cause gingival hyperplasia, it is primarily used for **hypertension** or **angina**, not seizure disorder.
- The patient's primary condition is a seizure disorder, making nifedipine an unlikely cause of his oral symptoms in this context.
*Phenobarbital*
- Phenobarbital is an **antiepileptic drug** but is not typically associated with **gingival hyperplasia**.
- Its more common side effects include **sedation**, **cognitive impairment**, and dependence.
*Carbamazepine*
- Carbamazepine is another **antiepileptic drug** that can be used for seizure disorders, but **gingival hyperplasia** is not a characteristic side effect.
- It is more commonly associated with side effects such as **dizziness**, **ataxia**, and **bone marrow suppression** (aplastic anemia).
*Topiramate*
- Topiramate is an **antiepileptic drug** often used for various seizure types, but it does not cause **gingival hyperplasia**.
- Common side effects include **cognitive slowing**, **paresthesias**, and **weight loss**.
Question 65: A 39-year-old man presents to the primary care physician complaining of 6 months of increasing dyspnea and non-productive cough. He has a past medical history of asthma, hypertension, obesity, and hypercholesterolemia. On examination, you notice that he takes shallow breaths and the respiratory rate is 22/min. On auscultation, you notice bibasilar rales, wheezes, and a grade 2/6 holosystolic murmur. The vital signs include: temperature 36.7°C (98.0°F), blood pressure 126/74 mm Hg, and heart rate 74/min. He then undergoes an outpatient high-resolution chest computed tomography (CT) scan which reveals bibasilar honeycombing, a calcified granuloma, and a mildly enlarged mediastinal lymph node. Which of the following medications can cause or contribute to this man’s lung disease?
A. Amiodarone (Correct Answer)
B. Candesartan
C. Verapamil
D. Propranolol
E. Prednisone
Explanation: ***Amiodarone***
- **Amiodarone** is a known cause of **pulmonary fibrosis**, characterized by dyspnea, non-productive cough, and bibasilar rales, as seen in the patient.
- The CT findings of **bibasilar honeycombing** are consistent with interstitial lung disease, which can be induced by amiodarone.
- Amiodarone pulmonary toxicity can occur with chronic use and presents with the structural changes seen on this patient's CT scan.
*Candesartan*
- **Candesartan** is an **angiotensin receptor blocker (ARB)** primarily used for hypertension and heart failure.
- It is not typically associated with causing or contributing to pulmonary fibrosis or interstitial lung disease.
*Verapamil*
- **Verapamil** is a **calcium channel blocker** used for hypertension, angina, and arrhythmias.
- It is not known to cause pulmonary fibrosis or significant lung disease.
*Propranolol*
- **Propranolol** is a **non-selective beta-blocker** that can exacerbate bronchospasm in patients with asthma or COPD, potentially worsening respiratory symptoms.
- However, it does **not cause the structural lung changes** (honeycombing, interstitial fibrosis) seen on this patient's CT scan.
- While it could worsen his asthma symptoms, it does not explain the CT findings that indicate drug-induced pulmonary fibrosis.
*Prednisone*
- **Prednisone** is a **corticosteroid** often used to *treat* inflammatory lung conditions, including some types of interstitial lung disease.
- It does not cause pulmonary fibrosis; rather, it is broadly anti-inflammatory, and its long-term use can lead to other complications but not the fibrotic lung damage described.
Question 66: A 50-year-old man presents to an ophthalmologist with progressive decrease in his visual acuity over the last 6 months. He also mentions that he has become excessively sensitive to light over the same duration. Past medical history is significant for schizophrenia diagnosed in early adulthood which has been managed with an antipsychotic medication for the past 20 years. The ophthalmologist performs a slit lamp examination and notes discrete brown deposits on the corneal epithelium in both eyes. Which of the following antipsychotic drugs has this patient most likely been taking?
A. Chlorpromazine (Correct Answer)
B. Clozapine
C. Thioridazine
D. Haloperidol
E. Ziprasidone
Explanation: ***Chlorpromazine***
- **Chlorpromazine** is known to cause **corneal and lenticular opacities** due to drug accumulation, presenting as **discrete brown deposits** on the **corneal epithelium** and lens.
- This side effect can lead to **decreased visual acuity** and **photosensitivity**, matching the patient's symptoms.
*Clozapine*
- Clozapine is primarily associated with **agranulocytosis** and **myocarditis**, not significant ocular deposits.
- While it can cause blurry vision, it does not typically manifest as discrete brown corneal deposits.
*Thioridazine*
- **Thioridazine** is notorious for causing **retinal pigmentation** (retinopathy), particularly at higher doses, leading to **visual impairment**.
- However, it does not typically cause the **corneal epithelial deposits** described in the patient.
*Haloperidol*
- **Haloperidol** is a potent typical antipsychotic with a high risk of **extrapyramidal symptoms**.
- It is not prominently associated with ocular side effects like corneal deposits or significant photosensitivity.
*Ziprasidone*
- **Ziprasidone** is an atypical antipsychotic with a risk of **QT prolongation** and metabolic side effects.
- It does not cause the specific corneal and lenticular changes seen with chlorpromazine.
Question 67: A 68-year-old male with congestive heart failure recently had his medication regimen adjusted to better control his hypertension. Three weeks later, laboratory analysis shows his serum calcium and magnesium levels have both decreased. The diuretic used in this patient acts predominantly on which nephron segment:
A. Distal tubule
B. Descending loop of Henle
C. Proximal tubule
D. Thick ascending loop of Henle (Correct Answer)
E. Cortical collecting duct
Explanation: ***Thick ascending loop of Henle***
- Diuretics acting on the **thick ascending loop of Henle** (e.g., **furosemide**) inhibit the **Na+-K+-2Cl- cotransporter**, reducing the reabsorption of these ions.
- This also significantly reduces the **lumen-positive transepithelial potential difference**, which is the driving force for **paracellular reabsorption of calcium and magnesium**, leading to their increased excretion and decreased serum levels.
*Distal tubule*
- Diuretics acting on the **distal tubule** (e.g., **thiazides**) inhibit the **Na+-Cl- cotransporter**.
- While they cause natriuresis, they paradoxically **increase calcium reabsorption** by enhancing activity of the basolateral Na+-Ca++ exchanger, leading to hypercalcemia, not hypocalcemia.
*Descending loop of Henle*
- The **descending loop of Henle** is primarily permeable to **water** but not solutes.
- Diuretics that affect this segment (e.g., ADH antagonists) would primarily impact water reabsorption without directly altering calcium and magnesium reabsorption in a way that causes hypocalcemia and hypomagnesemia.
*Proximal tubule*
- The **proximal tubule** is responsible for reabsorbing a large proportion of filtered calcium and magnesium, but diuretics acting here (e.g., **acetazolamide**) primarily inhibit bicarbonate reabsorption.
- While they can increase calcium and magnesium excretion to some degree, they are not typically associated with the pronounced hypocalcemia and hypomagnesemia seen with loop diuretics.
*Cortical collecting duct*
- The **cortical collecting duct** is targeted by **potassium-sparing diuretics** (e.g., **spironolactone**, **amiloride**).
- These diuretics inhibit sodium reabsorption and potassium secretion, but they do not significantly impact calcium or magnesium levels; in fact, some may even slightly increase calcium reabsorption.
Question 68: A 47-year-old man with alcoholic cirrhosis is brought to the emergency department by ambulance 20 minutes after being involved in a high-speed motor vehicle collision. His pulse is 120/min, respirations are 28/min and labored, and blood pressure is 70/40 mm Hg. Physical examination shows ecchymoses over the trunk and abdomen. In preparation for an exploratory laparotomy, atracurium is administered as an anesthetic. Which of the following characteristics is the most likely reason that this drug was chosen over other drugs in the same class?
A. Quickest onset of action
B. Highest potency
C. Prolonged depolarization
D. Organ-independent elimination (Correct Answer)
E. Low risk of bleeding
Explanation: ***Organ-independent elimination***
- **Atracurium** is metabolized by **Hofmann elimination** and **ester hydrolysis**, which are independent of renal or hepatic function.
- This is crucial for a patient with **alcoholic cirrhosis** and **hemodynamic instability**, where liver and kidney function may be compromised, preventing drug accumulation.
*Quickest onset of action*
- While a rapid onset is desirable in an emergency, atracurium does not have the **quickest onset of action** among neuromuscular blockers; **succinylcholine** is faster.
- The primary selection criterion here relates to the patient's underlying liver pathology and the drug's elimination profile.
*Highest potency*
- **Potency** refers to the dose required to produce a given effect, and while important, it is not the **most critical factor** in selecting atracurium for this patient.
- The patient's severe medical condition necessitates drug selection based on **metabolic profile** to minimize adverse effects.
*Prolonged depolarization*
- Atracurium is a **non-depolarizing neuromuscular blocker**, meaning it does not cause prolonged depolarization.
- **Succinylcholine** is a depolarizing agent, and its use might be contraindicated or require careful consideration in trauma patients with potential electrolyte imbalances.
*Low risk of bleeding*
- The risk of bleeding is generally not a direct characteristic of **neuromuscular blocking agents** themselves.
- The patient's **cirrhosis** and **trauma** are the primary factors contributing to a high risk of bleeding, which is managed independently of muscle relaxant choice.
Question 69: A 52-year-old woman with hypertension and type 2 diabetes mellitus comes to the physician because of a 1-day history of severe pain and swelling of her left great toe. She has had similar episodes sporadically over the past 3 years. She drinks 6 beers daily. She does not smoke or use illicit drugs. She is allergic to hydrochlorothiazide and glipizide. Her current medications are amlodipine and metformin. Examination shows erythema, warmth, and tenderness of the left first metatarsophalangeal joint and a nodule over the right elbow. The most appropriate next step in treatment is the administration of a drug that has which of the following mechanisms of action?
A. Selective inhibition of cyclooxygenase-2
B. Increased renal excretion of uric acid
C. Irreversible inhibition of cyclooxygenase
D. Reversible inhibition of prostaglandin synthesis (Correct Answer)
E. Irreversible inhibition of xanthine oxidase
Explanation: ***Reversible inhibition of prostaglandin synthesis***
- The patient presents with classic symptoms of an acute **gout flare**, including severe pain, swelling, erythema, and tenderness of the left great toe (podagra), with a history of similar episodes and an elbow nodule (tophi).
- **NSAIDs** (e.g., indomethacin, ibuprofen, naproxen) are first-line agents for acute gout attacks due to their rapid anti-inflammatory effects through the **reversible inhibition of cyclooxygenase (COX-1 and COX-2)**, thereby blocking prostaglandin synthesis.
*Selective inhibition of cyclooxygenase-2*
- **COX-2 selective inhibitors** (coxibs) can be used for acute gout flares, particularly in patients at higher risk of gastrointestinal bleeding.
- However, they are generally not preferred over non-selective NSAIDs due to potential cardiovascular risks, and the question asks for the **most appropriate** general mechanism, which broadly encompasses prostaglandin synthesis inhibition by non-selective NSAIDs as well.
*Increased renal excretion of uric acid*
- This mechanism describes **uricosuric agents** (e.g., probenecid, lesinurad), which are used for **long-term management of hyperuricemia** to prevent future gout flares, not for treating an acute attack.
- They work by inhibiting uric acid reabsorption in the renal tubules and are contraindicated in patients with a history of kidney stones.
*Irreversible inhibition of cyclooxygenase*
- This mechanism refers primarily to **aspirin** (acetylsalicylic acid), particularly at low doses.
- While aspirin is an NSAID, it is generally **avoided in acute gout** because it can both inhibit uric acid excretion (at low doses) and compete with uric acid for secretion, potentially worsening hyperuricemia or triggering a flare.
*Irreversible inhibition of xanthine oxidase*
- This mechanism describes **xanthine oxidase inhibitors** (e.g., allopurinol, febuxostat), which are used for **long-term management of hyperuricemia** by reducing uric acid production.
- These drugs are typically initiated after an acute flare has resolved, as they can sometimes precipitate a flare if started during an acute attack.
Question 70: A 20-year-old premedical student travels abroad for a global health service semester and presents to the local clinic with palpitations. She initially dismissed these symptoms as a side effect of working too hard; however, she has been noticing that these episodes have increased in frequency. Otherwise, she has had headaches and episodes of sweating, but she says that many members of her family have migraines. In the clinic, her temperature is 99°F (37°C), blood pressure is 170/120 mmHg, pulse is 105/min, respirations are 20/min. Other laboratory testing is not available. The doctor provides an older medication that he says does not bind to the relevant receptor but instead blocks an upstream process. The drug provided most likely has which of the following mechanisms of action?
A. Cleavage of vesicular SNAP proteins
B. Inhibition of vesicular transporters
C. Replacement of vesicular contents
D. Inhibition of metabolite conversion (Correct Answer)
E. Inhibition of reuptake pathways
Explanation: ***Inhibition of metabolite conversion***
- This patient's symptoms (palpitations, headaches, sweating, hypertension) point to a **pheochromocytoma**, which overproduces **catecholamines**. The drug described as not binding to the relevant receptor but blocking an upstream process, suggests it inhibits an enzyme involved in catecholamine synthesis, such as **tyrosine hydroxylase** or **dopamine beta-hydroxylase**.
- **Metyrosine** is an example of such a drug; it inhibits **tyrosine hydroxylase**, thereby reducing the synthesis of catecholamines and managing symptoms associated with pheochromocytoma.
*Cleavage of vesicular SNAP proteins*
- This mechanism is associated with **botulinum toxin**, which cleaves **SNARE proteins** like SNAP-25, synaptobrevin, and syntaxin, preventing the release of acetylcholine.
- This would lead to muscle paralysis and is not relevant to the management of catecholamine excess.
*Inhibition of vesicular transporters*
- This mechanism involves drugs like **reserpine**, which inhibits the **vesicular monoamine transporter (VMAT)**, preventing the uptake and storage of norepinephrine and other monoamines into synaptic vesicles.
- While it reduces catecholamine release, the question states the drug "blocks an upstream process" rather than vesicular transport specifically, and reserpine directly impacts vesicular contents.
*Replacement of vesicular contents*
- This mechanism describes drugs like **clonidine** or **alpha-methyldopa**, which act as **false neurotransmitters** or agonists that lead to reduced sympathetic outflow. Alpha-methyldopa is converted to alpha-methylnorepinephrine, which is then stored in vesicles displacing natural norepinephrine.
- While relevant to hypertension, this is a replacement, not an inhibition of an upstream synthetic process.
*Inhibition of reuptake pathways*
- This mechanism is characteristic of **tricyclic antidepressants (TCAs)** or **selective serotonin reuptake inhibitors (SSRIs)**, which increase the concentration of neurotransmitters in the synaptic cleft by blocking their reuptake into the presynaptic neuron.
- This would *increase* the effects of catecholamines, worsening the patient's symptoms, and is generally not used for chronic hypertension, especially in the context of pheochromocytoma.